Conference abstract · 14 Apr 2025
Byline
F. Frapaise
Articles whose byline reads F. Frapaise, printed most often as Francois Xavier Frapaise, Francois-Xavier Frapaise, F.X. Frapaise, FX Frapaise and Dr. Francois-xavier frapaise. Different authors can share a byline.
- Articles
- 23
- Latest year
- 2025
Articles
Newest first. Showing 1–23 of 23 articles.
Conference abstract · 4 Apr 2024
Leveraging gene-editing technology to enable production of low-cost biotherapeutics
Conference abstract · 4 Apr 2024
What is the real value of phase three trials in biosimilars assessment?
Conference abstract · 4 Apr 2024
What is the real value of phase three trials in biosimilars assessment?
Conference abstract · 4 Apr 2024
Leveraging gene-editing technology to enable production of low-cost biotherapeutics
Conference abstract · 3 Oct 2023
From biosimilars to affordable copies of biologics; access opportunities, scientific and regulatory challenges and emerging solutions
Conference abstract · 23 Jun 2023
From biosimilars to affordable copies of biologics; access opportunities, scientific and regulatory challenges and emerging solutions
Conference abstract · 3 Apr 2023
A new generation of technology platform for biosimilars production: Available, affordable, sustainable
Conference abstract · 3 Apr 2023
The end of phase 3 systematic confirmatory clinical trials in biosimilars development, are all stakeholders aligned?
Conference abstract · 3 Apr 2023
The end of phase 3 systematic confirmatory clinical trials in biosimilars development, are all stakeholders aligned?
Conference abstract · 11 Nov 2022
The End of Phase 3 Clinical Trials in Biosimilars Development?
Conference abstract · 27 Aug 2022
The end of Phase 3 clinical trials in biosimilars development?
Conference abstract · 15 Mar 2021
Blockchain in clinical research opportunities for enhanced consent form traceability, regualtory compliance and cost reduction
Conference abstract · 18 Mar 2020
Blockchain In Clinical Research
Conference abstract · 13 May 2019
The end of phase 3 clinical trials in biosimilars development
Conference abstract · 18 Mar 2019
Access to Biosimilars: a modern form of the Social Contract?
Conference abstract · 18 Mar 2019
The end of phase 3 clinical trials in biosimilars development
Conference abstract · 6 Mar 2019
Pharmaceutical: Clinical development strategy and technology
Conference abstract · 15 Nov 2018
The end of biosimilars phase 3 clinical trials?
Conference abstract · 15 Nov 2018
Patients education on biosimilars
Conference abstract · 24 Oct 2018
The end of clinical trials in biosimilars development?
Conference abstract · 24 Oct 2018
The end of clinical trials in biosimilars development?
Conference abstract · 24 Oct 2018

